Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CTI BioPharma Corp. CTIC

Healthcare Biotechnology
CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.


NDAQ:CTIC - Post by User

CTI BioPharma Corp.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3076)
•••
Post by Goldy63on Mar 04, 2022 12:48pm
115 Views
Post# 34483817

Monday Feb 7th . Numbers= $$$ = BOOM .

Monday Feb 7th . Numbers= $$$ = BOOM .

CTI BioPharma to Present at the Cowen 42nd Annual Healthcare Conference

 

 
CTIC | 23 hours ago

SEATTLE, March 2, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen Annual Healthcare Conference at 1:30 p.m. ET. The conference will be held in a virtual meeting format.

(PRNewsfoto/CTI BioPharma Corp.)

Presentation details:
Event: Cowen 42nd Annual Healthcare Conference
Date: Monday, March 7, 2022
Time: 1:30 p.m. ET


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities